The U.S. Food and Drug Administration (FDA) has cleared advanced visualization and image analytics software developer Qmenta's cloud-based Platform for Care.
The 510(k) clearance means qualified physicians can use the artificial intelligence (AI)-powered platform to manage imaging and other data across a network via web and customized user interfaces. That imaging and data can be processed by accessing and using integrated AI tools for imaging analysis and reporting.
The AI tools are hosted in the Qmenta Medical Imaging AI Analyses Catalog, a set of more than 50 marketed and research-only AI algorithms from verified scientific leaders focused on neurology, Qmenta said.
